Healthcare

SKP knows Healthcare…

  • Worked with 24 of the 25 largest global pharmaceutical companies and 5 of the 6 leading biotechnology companies
  • Devised strategies for 4 of the 10 best-selling drugs worldwide
  • Completed over 50 projects that included a US managed care strategy segment
  • Conducted healthcare projects in more than 30 countries
  • Devised strategies for more than 20 medical device products

SKP has offices in the 5 largest healthcare markets: USA, Japan, Germany, UK, France We are prepared to help clients strategically maximize profits at any stage in a product’s lifecycle such as product launch, market repositioning, and defensive tactics.

SKP can improve profitability throughout the product lifecycle

Please click on the figure in the right column for details on the "SKP Enhanced Product Cashflow".

SKP Healthcare Client References (selection)

  • Abbott
  • Asta Medica
  • AstraZeneca
  • Aventis
  • BASF
  • Bayer
  • Beiersdorf
  • Biogen
  • Boehringer Ingelheim
  • Byk Gulden
  • Chiron
  • CibaVision
    		•
  • Cordis
  • DuPont Deutschland
  • Eli Lilly
  • Ferring
  • Fujisawa
  • Genzyme
  • Glaxo SmithKline
  • Hoffmann-La Roche
  • Janssen Pharma
  • Knoll
  • Lipha
  • Madaus
  • Mallinckrodt Medical
  • Merck Sharp & Dohme
    		•
  • Novartis
  • Nycomed
  • Orion
  • Pfizer
  • Pharmacia
  • Sankyo
  • Schering
  • Schering-Plough
  • Schwarz Pharma
  • Transk. Therapies
  • Wyeth
    		•

    SKP Healthcare Publications (selection)

    Janssen Volker, Kucher Eckhard
    Strategies for Success
    Once a drug has cleared all its clinical and regulatory hurdles, it has still one final leap to make - success in the marketplace
    Scrip Magazine
    2004, April, 2004


    Kucher Eckhard
    The Euro and Pharmaceutical Pricing in Europe
    Reimbursement, Pharmacoeconomics, and Disease Management
    Spectrum Life Sciences
    2000, March 24, 2000, page 3-1


    Krütten Jörg
    Putting Benchmarking into Pharmaceutical Practice New Benchmarking models are not necessarily the way to superior performance Pharma Marketing Journal 1999, No. 1, Februar/März 1999, Wettbewerbsorientierung, pp. 6-14


    Kucher Eckhard, Simon Hermann
    The European Price Corridor And How to Implement it
    European Business Report
    1993, 3. Quartal, Autumn 1993, p. 10-16


    Kucher Eckhard
    An international strategy for pricing and profits
    Scrip Magazine
    1997, September 1997, Talking Points, pp. 30-32


    Hilleke Klaus, Kucher Eckhard
    Exploiting the profit potential of new drugs in Europe
    Scrip Magazine
    1992, November 1992, Pricing, pp. 30-33


    Partners of the SKP Life Science Division

    Bonn, Germany
    Klaus Hilleke
    Eckhard Kucher
    Jörg Krütten
    Volker Janssen

    Boston, USA
    Thomas Buchholz
    Steve Rosen
    Juan Rivera
    Razmic Gregorian





    © 2008 Simon - Kucher & Partners | Copyright

    go to the top ...